Rituximab and GM-CSF in Treating Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT00265915 · TERMINATED
Trial details
- NCT number
- NCT00265915
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2006-03-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.